Adamantinoma

Adamantinoma
Introduction
Rare low-grade malignant tumor of unknown etiology that is almost always located in the mid-tibia
- Epidemiology
- incidence
- less than 300 cases have been documented
- demographics
- occurs in young adults (20 - 40 years of age)
- Associated conditions
- osteofibrous dysplasia
Historically, it was thought that osteofibrous dysplasia (OFD) was a precursor to this adamantinoma, however current studies have cast doubt on this theory
- Prognosis
- may metastasize to lungs (25%), therefore long-term follow-up is recommended
- recurrence is uncommon with negative margin excision
Treatment
Operative
- wide-margin surgical resection
- indications
- standard of care in most patients
- techniques
- often requires intercallary resection with allograft or intercallary megaprosthesis reconstruction as adamantinoma is a low-grade malignancy, radiotherapy and/or chemotherapy is not typically used for local control of disease
Differentials & Treatment Groups
- Osteofibrous dysplasia
- differentiating between osteofibrous dysplasia and adamantinoma is critical
- osteofibrous dysplasia is benign and treated with observation
- adamantinoma is malignant and treat with surgical resection
Feel free to share your research work on related topics in Journal of Orthopedic Oncology which offers information in all aspects of primary, malignant tumors. Osteosarcoma, Ewing's sarcoma, chondrosarcoma, chordoma, and soft tissue sarcomas etc., it also deals with diagnostic methods, therapeutic approaches, clinical, laboratory research and reconstructive techniques.
Journal uses Editorial Tracking System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Orthopedics & Oncology or outside experts; at least two independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system.
Journal Considers Research article, Review articles, editorial, letter, case reports, short communications, original articles from leading scientists and scholars around the world in all areas of related to Malignantosteoid, Multilobular tumour of bone, Chondrosarcoma, Chordoma, Osteosarcoma, Ewing's sarcomaetc., which come under the scope of the journal.
- You may submit your manuscript as an e-mail attachment to the Editorial Office at orthooncol@scholarlymed.com; joo@jpeerreview.org
- Regards,
- Stella
- Editorial Team
- Journal of Orthopedic Oncology